Page last updated: 2024-11-03

propofol and Anticholinergic Syndrome

propofol has been researched along with Anticholinergic Syndrome in 1 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Anticholinergic Syndrome: Adverse drug effects associated with CHOLINERGIC ANTAGONISTS. Clinical features include TACHYCARDIA; HYPERTHERMIA; MYDRIASIS, dry skin and dry mucous membranes, decreased bowel sounds and urinary retention in peripheral anticholinergic syndrome; and HALLUCINATIONS; PSYCHOSES; SEIZURES; and COMA in central anticholinergic syndrome.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lock, G1
Reinhardt, A1
Waldmann, K1
Menne, U1

Other Studies

1 other study available for propofol and Anticholinergic Syndrome

ArticleYear
Central Anticholinergic Syndrome after Propofol Sedation for Upper GI Endoscopy.
    The American journal of gastroenterology, 2017, Volume: 112, Issue:8

    Topics: Abdominal Pain; Anticholinergic Syndrome; Endoscopy, Gastrointestinal; Female; Humans; Hypnotics and

2017